Gene Query: MAP4K1

Dataset Description Geneva Score
Transcriptomic profiling of O-GlcNAcylated mRNA-protein complexes by using OG-CLAP in HeLa cells. 60.56
Transcription control by the ENL YEATS domain in acute leukemia [RNA-seq] 55.51
Transcription control by the ENL YEATS domain in acute leukemia 55.51
Multiplex Single Cell Profiling of Chromatin Accessibility by Combinatorial Cellular Indexing [RNA-seq] 53.85
Multiplex Single Cell Profiling of Chromatin Accessibility by Combinatorial Cellular Indexing 53.85
Gene expression changes associated with resistance to tagraxofusp (SL-401) 42.67
Metabolic reprogramming of Kaposi’s sarcoma associated herpes virus infected B-cells in hypoxia 35.83
Distinct epigenomes in CD4+ T cells of newborns, middle-ages and centenarians. 31.35
The mechanism of HHT in treating acute myeloid leukemia on RNA level. 30.03
ChIP-seq and RNA-seq from human lymphoma cell lines 28.67
RNA-seq data from human lymphoma cell lines 28.67
The role of antigen presenting cells in the induction of HIV-1 latency in resting CD4+ T-cells 28.27
SRSF2 mutations impair hematopoiesis and alter exon recognition 26.4
Effect of ROQUIN2(Y691F) expression on mRNA levels upon BCR stimulation 26.03
A novel tumor-associated myeloid cell population inhibits antigen-specific immune responses in cancer patients 25.04
Next Generation Sequencing Facilitates Quantitative Analysis of transcriptomes of human cord blood CD34+ cells treated with HDAC5 inhibitor 23.39
Phosphatase inhibitor PPP1R11 modulates resistance of human T cells towards Treg-mediated suppression of TCR signaling 23.06
RNA-seq analysis of human KMT2A rearranged MV4;11 AML cell line treated with DOT1L and/or EZH2 inhibitor 22.45
Stimulation of isolated plasmacytoid dendritic cells (pDCs) with TLR9 agonist CpG C (CpG) and TLR7 agonist imiquimod (IMQ) 22.18
Generation of a Panel of Induced Pluripotent Stem Cells From Chimpanzees: a Resource for Comparative Functional Genomics (RNA-Seq) 20.16
Generation of a Panel of Induced Pluripotent Stem Cells From Chimpanzees: a Resource for Comparative Functional Genomics 20.16
Epigenetic Therapy Increases Therapeutic Efficacy in Myeloproliferative Neoplasms Through Inhibition of Aberrant Inflammatory Signaling 20.06
Total RNA-seq in ALL-SIL upon JQ1 inhibition 17.37
m6A level and isoform characterization sequencing (m6A-LAIC-seq) reveal the census and complexity of the m6A epitranscriptome 17.08
RNA sequencing with KSHV infection and enrichment for circular RNAs 16.25
MYCi975 regulates MYC target genes 16.11
Global analysis of alternative splicing regulated by RBM10 15.44
Gene expression profile of regenerated CD8αα T cells and CD8αβ T cells from LMP2 T-iPSCs 15.41
Controlling for gene expression changes in transcription factor protein networks. 15.4
Transcriptome of activated human and mouse MAIT cells 15.01
Plasma cell mitochondrial pyruvate import controls the duration of humoral immunity. 14.5
RNASeq of MV4;11 cells transduced with scramble shRNA or BRD4 shRNA in combination with DMSO or SGC0946 14.34
Transcriptome analysis of dominant-negative Brd4 mutants identifies Brd4-specific target genes of BET inhibitor JQ1 14.31
Gene Expression Profiling of Cutaneous CD30+ Lymphoproliferative Disorders by RNA-seq 14.15
SHQ1 regulation of RNA splicing is required for T-lymphoblastic leukemia cell survival 13.88
Transcriptome-wide analysis of the role of HTLV-1 Tax PBM in T-Cells from infected humanized-mice (hu-Mice) 12.89
Whole Transcriptome RNASeq Data for Cell-Sorted Antibody Secreting Cells (ASC) 12.69
Epigenetic silencing of the tumor suppressor RASSF4 favors multiple myeloma progression 12.32
Cancerous inhibitor of PP2A (CIP2A) Constrains Th17 Differentiation by Modulating STAT3 Signaling 12.1
Global Bidirectional Transcription of the Epstein-Barr Virus Genome During Reactivation 11.91
Transcriptional change of THP-1 after HSV-1UL37WT or HSV-1UL37C819S 11.74
Intrahepatic MAIT cell gene expression revealed by RNA-seq 11.61
Transcriptome wide analysis of classically and alternatively activated macrophages 11.59
Quantitative mass spectrometry-based proteomics reveals the dynamic protein landscape during initiation of human Th17 cell polarization 11.55
Transcriptomes change differerntly in differernt cancer cells upon EPZ-6438 treatment 11.54
Transcriptome of Stabilin-1 siRNA transfected human monocytes 10.9
3D genome of multiple myeloma reveals spatial genome disorganization associated with copy number variations 10.72
Reprogramming of Endothelium Into Hematopoietic Progenitors by Defined Factors and Vascular Induction 10.48
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma (RNA-Seq) 10.39
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma 10.39
CD97 is a Critical Regulator of Acute Myeloid Leukemia Stem Cell Function 10.2
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs with in vivo activity in hematological malignancies 10.17
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs with in vivo activity in hematological malignancies [RNA-Seq] 10.17
IL-1β induces the rapid secretion of the antimicrobial protein IL-26 from Th17 cells 10.13
RNA expression analysis upon JMJD1C depletion 10.13
JMJD1C is required for the survival of acute myeloid leukemia by functioning as a co-activator for key transcription factors 10.13
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation (RNA-Seq) 10.13
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation 10.13
Gene expression comparison of resting human peripheral-blood NK cells and activated counterparts 9.96
Endothelial TGFb signaling drives vascular inflammation and atherosclerosis 9.76
Endothelial TGFb signaling drives vascular inflammation and atherosclerosis [bulk RNA-Seq] 9.76
Improved LCL to iPSC reprogramming: RNA Analysis of LCLs, reprogrammed iPSCs, and differentiated NSCs reveal potential regulatory and functional processes involved in these cellular transitions. 9.75
Amiloride, an old diuretic drug, is a potential therapeutic agent for multiple myeloma 9.55
Potent and targeted activation of HIV-1 using the CRISPR/Cas9 activator Complex 9.5
A CLK3-HMGA2 alternative splicing axis impacts human hematopoietic stem cell molecular identity throughout development [BM low-input mRNA-seq] 9.38
Human Treg NaCl stimulation 9.28
mRNA expression profile of Lymphocytes by high-throuput sequencing 9.18
RNAi profiling of primary human AML cells identifies ROCK1 as a therapeutic target and nominates Fasudil as an anti-leukemic drug. 9.14
Widespread intronic polyadenylation diversifies immune cell transcriptomes 8.95
Single cell RNA sequencing reveals microglia-like cells in cerebrospinal fluid  during virologically suppressed HIV 8.65
SnapShot-Seq: a method for extracting genome-wide, in vivo mRNA dynamics from a single total RNA sample 8.61
Impact of dieldrin on transcription in Jurkat T cells 8.59
RNAseq of T-ALL upon long non coding rna purturbation 8.37
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells (mRNA-Seq) 8.25
Expression profiles of long non-coding RNAs located in autoimmune disease-associated regions reveal immune cell type specificity 8.24
Gene expression profiles of primary human NK cells before and after expansion on CSTX002 feeder cells, with and without IL-21 stimulation 8.2
Gene expression signatures of innate lymphoid cells from human blood 8.18
RNA-seq analysis of activated plasmacytoid dendritic cell subsets after viral infection 8.04
Overexpression of ERG in cord blood progenitors promotes expansion and recapitulates molecular signatures of high ERG leukemias 7.91
Identification of Tissue-Specific Protein-Coding and Noncoding Transcripts across 14 Human Tissues Using RNA-seq 7.8
Interaction with WDR5 recruits MYC to a small cohort of genes required for tumor onset and maintenance 7.75
Gene expression changes in THP1 cells at day 2 and 4 following shRNA knock-down of RUVBL2 7.74
Transcriptional profiling of PBMC from patients with aGvHD and patients without aGvHD after alloHSCT 7.65
Lymphocyte-specific chromatin accessibility pre-determines glucocorticoid resistance in acute lymphoblastic leukemia 7.65
Lymphocyte-specific chromatin accessibility pre-determines glucocorticoid resistance in acute lymphoblastic leukemia [RNA-seq] 7.65
Molecular Biomarkers Screened by Next-generation RNA Sequencing for non-sentinel lymph node status predicting in breast cancer patients with metastatic sentinel lymph node 7.61
Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma 7.58
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 1: RNA-seq) 7.51
Dynamics of Proteo-Transcriptomic Response to HIV-1 Infection 7.38
RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer 7.32
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor 7.02
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor [RNA-seq] 7.02
A practical evaluation of alignment algorithms for RNA variant calling analysis 7.0
Expression and functions of long noncoding RNAs during human T helper cell differentiation 7.0
Stem and effector CD8 T-cells from human cancers 6.81
The role of FAM46C in myeloma cells 6.8
The role of FAM46C in myeloma cells [sequencing] 6.8
m6A-RNA mapping, SND1-RNA binding profile mapping and SND1-depletion in KSHV-infected B-lymphocytes 6.65
RNA-sequencing of bulk CD19+ Thymic B cells from young (3 month - 4 year) and old (42 - 61 years) humans 6.6
RNA-sequencing of bulk CD19+ Thymic B cells from mice and humans 6.6
Therapeutic targeting of GCB- and ABC-DLBCLs by rationally designed BCL6 inhibitors 6.6
EZH2 and BCL6 cooperate to assemble CBX8-BCOR Polycomb complex to repress bivalent promoters, mediate germinal center formation and promote lymphomagenesis [RNA-seq] 6.49
EZH2 and BCL6 cooperate to assemble CBX8-BCOR Polycomb complex to repress bivalent promoters, mediate germinal center formation and promote lymphomagenesis 6.49
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation (RNA-Seq) 6.47
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation 6.47
Non-coding regions are the main source of tumor-specific antigens 6.39
Non-coding regions are the main source of tumor-specific antigens [human] 6.39
IL-6/Stat3-Dependent Induction of Distinct, Obesity-Associated Natural Killer Cells Deteriorates Energy and Glucose Homeostasis 6.37
Comparison between THP-1 cells obtained from either ATCC or DSMZ biorepository 6.37
Comparison of the transcriptome and chromatin state between human cord blood HSC and human iPSC derived hematopoietic progenitor using next-generation sequencing 6.27
Heterogeneous maintenance of human tissue resident memory T cells based on efflux capacities 6.23
Gene expression profile of multiple myeloma cell lines treated with CB-5083 6.1
Comparative genome-wide analysis of human BM IL3Rα-high precursors show a more MΦ-, DC- and OC committed gene expression profile, as compared to IL3Rα-low precursors 6.05
Isolation and Transcriptome Analyses of Human Erythroid Progenitors: BFU-E and CFU-E 6.01
Allelic expression mapping across cell lineages reveal repressor disruption among disease SNPs 6.0
The CDK7 Inhibitor THZ1 Alters RNA Polymerase Dynamics at the 5’ and 3’ Ends of Genes 5.96
The effects of U1 snRNA mutation in chronic lymphocytic leukemia cell lines 5.93
A Druggable TCF4- and BRD4-dependent Transcriptional Network Sustains Malignancy in Blastic Plasmacytoid Dendritic Cell Neoplasm (RNA-Seq) 5.91
Helios enhances the preferential differentiation of human fetal CD4+ naïve T cells into regulatory T cells. [RNA-Seq - ex vivo] 5.91
Targeting Chromatin Regulators Inhibits Leukemogenic Gene Expression in NPM1 Mutant Leukemia 5.85
The long non-coding RNA MALAT1 contributes to the pathogenesis of multiple sclerosis through alternative splicing and backsplicing regulation 5.83
Effect on small molecule RBPJ inhibitor (RIN1) on gene expression in Jurkat cells compared to gamma secretase inhibition and siRNA knockdown of RBPJ 5.81
Mutational landscape of aggressive natural killer-cell leukemia and drug profiling highlight JAK-STAT signaling as a therapeutic target in NK-cell malignancies 5.78
Transcriptional Modulation of Human Endogenous Retroviruses in Primary CD4+ T Cells Following Vorinostat Treatment 5.78
Modulation of SF3B1 causes global intron retention and downregulation of the B-cell receptor pathway in chronic lymphocytic leukemia 5.53
Gene expression profile of human multiple myeloma cell line MM.1S after knockdown of KDM6B 5.52
Comparative Analysis of the Transcriptome of Latent Autoimmune Diabetes (LADA) Patients from Eastern China 5.49
Enhancement of Human B Cell Differentiation and Function in Lymph Nodes by the TLR9 Agonist MGN1703 5.49
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 [RNA-seq] 5.43
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 5.43
Landscape and variation of RNA secondary structure across the human transcriptome 5.38
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 2: scRNA-seq) 5.35
Tissue-resident memory T cells mediate immune homeostasis in the human pancreas through the PD-1/PD-L1 pathway 5.35
TCR and inflammatory signals tune human MAIT cells to exert specific tissue repair and effector functions 5.18
Transcriptomics profiling of CD141+ dendritic cells isolated from peripheral blood or synovial fluid of arthritis patients 5.18
Characterization of human ILC2 subsets 5.09
RNA-seq of naive and primed ES cells 5.09
RNA-Seq study of Cell lines rendered resistant to idelalisib and ibrutinib 5.08
Human lymph nodes maintain a unique subset of resident memory T cells with high functional potential important for protective immunity and immunotherapies 5.03
Comparative total RNA and mRNA sequencing and systems analysis reveals nascent transcriptional response to early HIV-1 infection in a CD4+ T cell line 4.83
T47D RNA-seq and ChrRNA-seq data 4.81
Arginine citrullination at the C-terminal domain controls RNA Polymerase II transcription 4.81
Dysregulated immune system networks in war veterans with PTSD 4.81
RNA-seq profile of expanded human ST2-transduced Tregs cultured with IL-2 and TCR in the presence or absence of IL-33 4.78
CROP-Seq in Primary Human T Cells 4.77
Specific inhibition of DPY30 activity by peptides suppresses blood cancer cell growth 4.75
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma 4.74
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma (RNA-Seq) 4.74
Effector and regulatory T cells roll at high shear stress by inducible tether and sling formation 4.72
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo 4.65
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo [RNA-seq] 4.65
The impact of stanniocalcin 1 on the transcriptome of human cord blood stem/progenitors 4.64
CD161+ Tconv and Treg share transcriptome and display a migratory phenotype which is modified at the inflamed site 4.6
Human CD4+CD103+ cutaneous resident memory T cells are found in the circulation of healthy subjects 4.56
Single cell transcriptome of peritoneal cells 4.51
Global gene expression profile of dasatinib-resistant RCH-ACV cells 4.49
Single-Cell reconstruction of differentiation trajectory reveals essential dynamics in human cardiac lineage commitment 4.45
RNA-Seq analysis of human Tr1, Tregs and IL10neg cells 4.43
Functional Inflammatory Profiles Distinguish Myelin-Reactive T Cells from Patients with Multiple Sclerosis 4.39
Global gene expression analysis of human monocyte-derived dendritic cells (DCs) treated with HMGN1 (N1) and R848 alone or in combination. 4.37
Expression analysis of Mebendazole treated THP-1 cells in three paired samples 4.33
Functional characterization of human T cell hyporesponsiveness induced by CTLA4-Ig 4.33
Human MAIT cells exit peripheral tissues and re-circulate via lymph in steady state conditions 4.31
Transcriptome Profiling of Human Primary Monocytes 4.28
Human iPSC-derived microglia assume a primary microglia-like state after transplantation into the neonatal mouse brain [Single Cell RNAseq] 4.2
Hematopoietic Stem and Progenitor Cells from Human Pluripotent Stem Cells via Transcription Factor Conversion of Hemogenic Endothelium 4.15
Expression analysis of THP1 cells following shRNA knock-down of RUVBL2 4.13
Induction of Prolonged Early G1 Arrest by CDK4/CDK6 Inhibition Reprograms Lymphoma Cells for Durable PI3Kδ Inhibition Through PIK3IP1 4.05
Non-coding and coding transcriptional profiles are significantly altered in pediatric Retinoblastoma tumors 4.03
Generation and persistence of human tissue-resident memory T cells in lung transplantation 4.01
Next Generation Sequencing for Quantitative Analysis of transcriptome of follicular compared to non-follicular CD8 T cells from HIV+ Lymph nodes 3.99
Human primary macrophages derived in vitro from circulating monocytes comprise adherent and non-adherent subsets with differential expression of Siglec-1 and CD4 and permissiveness to HIV-1 infection 3.95
RNA-seq analysis of umbilical cord blood cells upon knockdown of NAP1L3 3.93
Reprogramming of Tumor-infiltrating Immune Cells in Early Stage of NSCLC 3.92
Critical role for Lymphocytes in Producing FLT3LG in Tumors and Driving Checkpoint Therapy-Receptive Immune Microenvironments 3.91
Absence of NKG2D ligands defines human leukaemia stem cells and mediates their immune evasion 3.84
Pharmacologic inhibition of STAT5 in AML 3.82
Transient stabilization, rather than inhibition of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma 3.78
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells 3.78
Innate-like activation of mucosal-associated invariant T cells in mycobacterial infection 3.76
The splicing factor RBM25 controls MYC activity in Acute Myeloid Leukemia 3.72
Identification of global regulators of T-helper cell lineage specification 3.71
Identification of global regulators of T-helper cell lineage specification (RNA-Seq) 3.71
BET bromodomain proteins function as master transcription elongation factors independent of CDK9 recruitment [NET-seq] 3.71
Time-Resolved Proteomics Extends Ribosome Profiling-Based Measurements of Protein Synthesis Dynamics 3.7
Analysis of transcriptomes of healthy donor and CD46 deficient CD8 T cells 3.68
Transcriptome analysis of CD8+ T cells from healthy controls and patients wth CD46 deficiency 3.68
Analysis of the polyA+ RNA of LPS-treated human CD14+ monocytes 3.65
FOXP3 protects conventional human T cells from premature restimulation-induced cell death 3.65
Blocking expression of inhibitory receptor NKG2A overcomes tumor resistance to NK cells 3.58
The BCL6 RD2 domain governs commitment of activated B-cells to form germinal centers 3.58
Activating PAX Gene Family Paralogs to Complement PAX5 Leukemia Driver Mutations 3.56
Immunological Imbalance in Fibrodysplasia Ossificans Progressiva Revealed by PBMC Transcriptome Analysis 3.55
Respecifying human iPSC-derived blood cells into highly engraftable hematopoietic stem and progenitor cells with a single factor 3.55
A Unique Epigenomic Landscape Defines Human Erythropoiesis (RNA-seq) 3.55
A Unique Epigenomic Landscape Defines Human Erythropoiesis 3.55
RNA-sequencing of formalin fixed human primary melanoma tissue 3.53
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [Nalm-6] 3.49
Transcriptome analysis of diverse cell types infected with human cytomegalovirus [RNA-Seq] 3.49
Cancer-Causing Mutations in SF3B1 Alter Splicing by Disrupting Interaction with SUGP1 3.43
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 3.4
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 3.4
Total RNA-Seq data from leukemic patients with complex structural variants 3.39
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration [Microfluidics] 3.36
RNA-seq in acute myeloid leukemia (AML) cells with and without knockdown of METTL14 3.34
Intron retention induced by microsatellite expansions as a disease biomarker. 3.33
RNA expression profiling of human mPB or CB-derived CD34+ cells treated with UM171 at different doses 3.29
CTCF and CohesinSA-1 Mark Active Promoters and Boundaries of Repressive Chromatin Domains in Primary Human Erythroid Cells [RNA-Seq] 3.26
CTCF and CohesinSA-1 Mark Active Promoters and Boundaries of Repressive Chromatin Domains in Primary Human Erythroid Cells 3.26
Trans-differentiation of human adult peripheral blood T cells into neurons 3.25
Oncolytic reactivation of KSHV as a therapeutic approach for primary effusion lymphoma: RNA-sequencing of PEL cell lines during KSHV reactivation 3.2
Transcriptomic responses to Ivacaftor and prediction of Ivacaftor clinical responsiveness 3.2
Mucosal Profiling of Pediatric-Onset Colitis and IBD Reveals Common Pathogenics and Therapeutic Pathways 3.16
Allergen-specific immunotherapy modulates the balance of circulating Tfh and Tfr cells 3.16
A recessive form of hyper-IgE syndrome by disruption of ZNF341-dependent STAT3 transcription and activity 3.14
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma (RNA-Seq) 3.11
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma 3.11
Sirt6 Oncogene Mediates PI3K/Akt Signaling Activation in Diffuse Large B-Cell Lymphoma 3.08
Transcriptome-wide identification of CELF2 functional targets in T cells 3.07
Immune-restricted epigenetic reader SP140 maintains macrophage identity and activation states critical to intestinal homeostasis [RNA-seq] 3.04
Immune-restricted epigenetic reader SP140 maintains macrophage identity and activation states critical to intestinal homeostasis 3.04
Targeting JNK Pathway Expands Human Hematopoietic Stem Cells 3.03
Whole blood RNAseq from Generalised Pustular Psoriasis patients and healthy individuals 3.02
Wnt1 silences CC/CXC motif chemokine genes in dendritic cells and induces adaptive immune resistance in lung adenocarcinoma 3.02
SETDB2 links E2A-PBX1 to cell cycle dysregulation in acute leukemia through CDKN2C repression [sequencing] 3.02
Transcriptomes in healthy and CHB fetal hearts 3.01
Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq B-ALL) 3.0
Whole transcriptome analysis of PBMCs stimulated with either a P. aeruginosa phage PNM lysate or with its bacterial host P. aeruginosa 3.0
CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape 3.0
Expression profile and potential functions of circulating long noncoding RNAs in acute ischemic stroke in the Southern Chinese Han population 2.99
The mithralog EC-7072 is highly cytotoxic to chronic lymphocytic leukemia cells by targeting the B-cell receptor signaling pathway 2.98
Treatment of multiple myeloma cells with EZH2 small molecule inhibitor 2.94
Monitoring Nivolumab binding as a method to clarify the residual therapeutic effects and to characterize the immune profile in antibody bound T cells in previously treated non-small cell lung cancer patients 2.92
RNA-seq transcriptional profiling in human primary fetal and adult CD34+ hematopoietic stem/progenitor cells (HSPCs) erythroid progenitor cells (ProEs) 2.92
Physiologic expression of Sf3b1K700E causes impaired erythropoieses, aberrant splicing, and sensitivity to pharmacologic spliceosome modulation 2.91
RNA-seq analysis of YFV-17D specific and total naive CD8 T cells in humans 2.91
naive T cell heterogeneity after neonatal thymectomy 2.89
Loss of CREBBP results in gene expression repression in lymphoma cells 2.88
Loss of CREBBP results in H3K27Ac loss at enhancers and gene expression repression in lymphoma cells 2.88
Zika virus antagonizes interferon response in patients and disrupts RIG-I-MAVS interaction through its CARD-TM domains 2.85
CD74 role in transcription regulation [RNA-seq] 2.84
CD74 role in transcription regulation 2.84
Differential expression of long non‑coding RNA and mRNA in children with Henoch‑Schönlein purpura nephritis 2.84
Definition of Natural Killer cell heterogeneity in humans and mice by high-throughput single-cell RNA sequencing 2.83
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation [RNA-seq] 2.83
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation. 2.83
Transcriptomic analysis of IPF lung-associated and normal peripheral blood T cells 2.83
Temporal comparison of transcriptomic alterations in human, mouse and rat primary B lymphocytes exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) 2.81
Tyrosine-1 of RNAPII CTD controls global termination of gene transcription in mammals 2.8
Hydroxychloroquine inhibits responses to group A streptococcus in peripheral blood mononuclear cells 2.8
mRNA expression levels in splenic human mononuclear cells of mock- and HIV-1-infected humanized mice 2.76
RNA-Seq in neutrophils from Antiphospholipid Syndrome 2.7
Transcriptomic profiling of nasopharyngeal carcinoma (NPC) and normal control samples 2.69
Transcriptomic profiling of mRNA and miRNA from nasopharyngeal carcinoma (NPC) and normal control samples 2.69
Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq AML development) 2.69
Integrative Genomic and Transcriptomic Analysis Identified Candidate Genes Implicated in the Pathogenesis of Hepatosplenic T-cell Lymphoma 2.67
Hepatosplenic T cell lymphoma 2.67
T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 2.66
Gene expression in TAL1-driven T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 2.66
CD86 regulates a pro-survival signal in myeloma cells 2.66
RNAseq of PRMT4KD in human cord blood derived CD34+ cells 2.66
Integrating single-cell transcriptomic data across different conditions, technologies, and species 2.64
Genome-wide Gene Expression Profiling in DLBCL Cell Lines Treated with CUDC-907 2.58
Dynamic 3D chromosomal landscapes in acute leukemia 2.58
Dynamic 3D chromosomal landscapes in acute leukemia [RNA-Seq] 2.58
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid 2.55
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid [TEMRA] 2.55
RNA-Sequencing experiment for effects of PKF115-584 treatment on four T-ALL cell lines (RPMI8402, HPB-ALL, Jurkat, CCRF-CEM). 2.53
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [RNA-Seq] 2.51
MAIT cell RNA sequencing 2.49
Evaluation of the immunogenicity of live-attenuated influenza vaccines in nasal epithelial cells in primary differentiated human nasal epithelial cells [RNA-Seq] 2.49
Evaluation of the immunogenicity of live-attenuated influenza vaccines in nasal epithelial cells in primary differentiated human nasal epithelial cells 2.49
Transcriptional profile in human S. haematobium infection 2.48
RNASeq of MV4;11 cell treated with DMSO, I-BET, SGC0946 and combination of I-BET and SGC0946 2.46
Functional interdependency of BRD4 and DOT1L in MLL leukaemia 2.46
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures [RNA-seq] 2.45
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures 2.45
Transcriptional profiles of normal human mature B cells 2.45
Transcriptome analysis of Riociguat and Vehicle control treatment in human hematopoietic stem and progenitor cells 2.45
Expression patterns in chronic thromboembolic pulmonary hypertension 2.45
Proteolytic cleavage by taspase1 and the regulation of the stability of MLL1 2.44
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition 2.41
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition [RNA-Seq] 2.41
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [SLAM-Seq] 2.41
Gene expression and splicing alterations analyzed by high throughput RNA sequencing of chronic lymphocytic leukemia specimens 2.39
Hijacking of stress response machinery by oncogenes in acute leukaemia [RNA-seq] 2.39
Hijacking of stress response machinery by oncogenes in acute leukaemia 2.39
Tissue-specific RNA-seq in human evoked inflammation identifies novel blood and adipose lincRNA signatures of cardio-metabolic diseases 2.38
RNA-Seq and expression data from human adipose tissue 2.38
RNA-Seq in human T-cell lymphoblastic lymphoma samples and control thymuses 2.38
Human T-cell lymphoblastic lymphoma samples and control thymuses 2.38
Gene expression analysis of human CD8+ T cells treated with a DOT1L inhibitor 2.38
Overexpression of UGT2B17 in MEC1 and JVM2 leukemia cell lines 2.36
Single-cell transcription profiling in KS1 patient iPSCs and NPCs 2.36
Differentially expressed genes from RNA-Seq and functional enrichment results are affected by the choice of single-end versus paired-end reads and stranded versus non-stranded protocols 2.34
Identification of long noncoding RNAs in T-ALL cell lines 2.3
Transcriptomic profiling of cleavage-resistant RIPK1 induced autoinflammation syndrome patients 2.29
Global Gene Expression analysis of CUTLL1 cell lines after treatment with Perhexiline 2.29
Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid 2.28
RNA-Seq from human ILC transitional populations 2.27
Expression profiling of ILC transitional populations and Aiolos accessability and H3K27ac histone modifications in transfected MNK3 cells 2.27
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis [RNA-Seq] 2.25
RNA-Seq profiling in PBMCs and spinal cord from ALS patients and healthy controls 2.22
Comprehensive RNA-Seq profiling in PBMCs of ALS patients and healthy controls 2.22
Functional significance of the HIV-1 Tat signature amino acid residues 2.19
RNA-Seq of CD4+ T cells treated with AS1842856 or DMSO 2.15
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation 2.11
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation (RNA-Seq) 2.11
Identifying a novel candidate diagnostic and prognostic biomarker SPRR3 for oral squamous cell carcinoma via mRNA Sequencing and Bioinformatics 2.1
Study functions of ADAR proteins using next generation sequencing of genome and transcriptome 2.09
Efficient direct reprogramming of c-Kit− mature amniotic cells into endothelial cells by ETS factors and TGFβ suppression 2.07
Agonistic targeting of TLR1/TLR2 induces p38 MAPK-dependent apoptosis and NfkB-dependent differentiation of AML cells 2.05
Induction and Therapeutic Targeting of Human NPM1c+ Myeloid Leukemia in the Presence of Autologous Immune System in Mice 2.03
RNAseq of CD8+ and CD8- MAIT cells in human peripheral blood 2.03
Functional separation of IL7Rα/KLRG1-defined CD8+ T cell populations in humans 2.03
Sequencing of messenger RNAs with N6-methyladenosine modifications in acute myeloid leukemia (AML) with and without forced expression of FTO 2.02
The pause-initiation limit restricts transcription activation in human cells 2.0
TT-seq captures simultaneous activation of eRNAs and promoters during T cell activation 1.99
Transcriptomic insights into human decidual and peripheral blood CD4 T cells 1.97
Enhanced T cell responses to IL-6 in type 1 diabetes are associated with early clinical disease and increased IL-6 receptor expression 1.97
Bone marrow derived human B cells [normal proB] 1.96
Human bone marrow resident natural killer cells have a unique transcriptional profile and resemble resident memory CD8+ T cells 1.95
Hit-and-run' programing of CAR-T cells using mRNA nanocarriers 1.94
Identification of novel recurrent ETV6-IGH fusions in primary central nervous system lymphoma using high throughput RNA sequencing 1.94
Characterisation of the myeloid differentiation process of human hematopoietic stem cells 1.91
Profiles of Long Noncoding RNAs in Human Naive and Memory T Cells 1.9
Be1 and Be2 B cells are transcriptionally distinct 1.83
Diarrhoeal mechanisms of the Campylobacter jejuni enteritis 1.82
Antioxidant metabolism in activated CD8+ T cells regulates stem-like human memory T cell formation and anti-tumor immunity 1.81
Stretch-Enhancers Delineate Disease-Associated Regulatory Nodes in T Cells 1.77
Single-cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment - 5' RNA sequencing and TCR sequencing 1.76
Identification of a dynamic core transcriptional network in t(8;21) AML regulating differentiation block and self-renewal [RNA-Seq] 1.75
Identification of a dynamic core transcriptional network in t(8;21) AML regulating differentiation block and self-renewal 1.75
RNA-Seq gene profiling comparison from human cDC subsets and pre-cDC subsets 1.74
Effect of BCL11B knockdown on transcriptome of human T-cell precursors 1.73
CircRNAome diversity in human mature B-cells, T-cells and monocytes 1.71
CLIC5: a novel ETV6 target gene in childhood acute lymphoblastic leukemia 1.71
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with pancreatic carcinoma 1.69
RNA-seq of ASXL2 shRNA KD in SKNO-1 cells 1.63
Gene expression in control and DOCK8 CRISPR KHYG1 NK cells 1.62
Charaterization of genetic alterations and gene expression signatures found in BCR-ABL inhibitor-resistant KCL-22 subpopulations and single clones 1.6
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [GSKJ4_RNA-seq] 1.6
Specific molecular signatures underlie response to decitabine in CMML 1.55
Specific molecular signatures underlie response to decitabine in CMML [RNA-seq] 1.55
XPO1 inhibition antagonizes MCL via nuclear retention of IkB: Selinexor demonstrates antitumor activities in both ibr-sensitive and ibr-resistant tumor cells 1.54
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [short_hairpins_RNA-seq] 1.53
Mllt3 Governs Self-Renewal And Engraftment Of Human Hematopoietic Stem Cells 1.51
RNA-seq of MLLT3-overexpressing cultued HSPC, compared to non-overexpressing and uncutured FL-HSPC [RNAseq_MLLT3_OE] 1.51
Single cell RNA-seq resolves lineage-specific activation dynamics of human blood and tissue T cells 1.5
RNA-seq of resting and activated CD4+ T cells +-JQ1 1.46
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles 1.42
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles (RNA-seq) 1.42
Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis 1.39
RNAseq of human monocyte cell line (U937-Cas9) WT or IRF2KO 1.36
A comprehensive gene expression analysis identifies novel immune signatures in cesarean-born infants 1.35
Antiviral and anti-inflammatory properties of novel anti-HIV candidate ABX464 promotes specifics RNA splicing while preserving cellular RNA integrity. 1.35
HuR controls apoptosis and activation response without effects on cytokine 3′ UTRs 1.35
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-Resistant, sensitive and healthy control 1.34
Allogeneic mature human dendritic cells generate superior alloreactive regulatory T cells in the presence of IL-15 1.3
JAK dependent survival of ALK- ALCL 1.3
NSD2 overexpression links drives clustered chromatin and transcriptional changes in a subset of insulated domains of insulated domains 1.29
ZFR coordinates crosstalk between RNA decay and transcription in innate immunity 1.29
MHC Transcriptomic landscape at haplotype-specific resolution 1.28
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing 1.28
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing (RNA-seq) 1.28
Pancreatic cancer-derived exosomes induce apoptosis of T lymphocytes through the p38 MAPK signal transduction pathway 1.24
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (scRNA-Seq) 1.24
JMJD3 facilitates C/EBPβ-centered transcriptional program to exert oncorepressor activity in AML 1.23
Expression of MERTK based on Multiple Sclerosis (MS) risk haplotype 1.23
Transcriptomic profiling of sequential tumours from breast cancer patients provides a global view of metastatic expression changes following endocrine therapy 1.23
Evolution of an lncRNA leads to a primate specific modulation of alternative splicing 1.22
The IMiDs, through loss of Ikaros and Aiolos, primes myeloma cells for daratumumab mediated killing by upregulation of CD38 1.22
Long noncoding RNA signatures induced by TLR7 and type I IFN signaling in activated human plasmacytoid dendritic cells 1.21
Mitochondrial hypoxic stress induces RNA editing by APOBEC3G in lymphocytes 1.19
RNA-seq of healthy CD34+ HSPCs after co-culture with myelodyplastic syndrome patient-derived mesenchymal stromal cells 1.18
Neural cell adhesion molecule 1 (NCAM1; CD56) promotes leukemogenesis and confers drug resistance in acute myeloid leukemia. 1.18
The Genetic Landscape of Diamond-Blackfan Anemia 1.14
RNA-seq data of small cell carcinoma of the bladder (SCCB) /urothelial carcinoma (Non-SCCB) clinical samples, and bladder-PARCB cell lines 1.13
Gene expression profiling of leukemia cells following asparagine depletion 1.13
B cells expressing the IgA receptor FcRL4 participate in the autoimmune response in patients with rheumatoid arthritis 1.12
Whole blood stabilization for the microfluidic isolation and molecular characterization of circulating tumor cells 1.11
Tafazzin Regulates Cell State by Modulating Phosphatidylethanolamine and Phosphatidylserine levels 1.1
Transcriptional changes during naturally-acquired ZIKA Virus infection render dendritic cells highly conducive to viral replication 1.08
Human Bone Marrow Assessment by Single Cell RNA Sequencing, Mass Cytometry and Flow Cytometry [bulk] 1.07
Transcriptional Down-regulation of CCR5 in a Subset of HIV+ Controllers (RNA-Seq) 1.05
Transcriptional Down-regulation of CCR5 in a Subset of HIV+ Controllers 1.05
Whole transcriptome profile of citrulline-specific B cells from patients with rheumatoid arthritis 1.04
Molecular Criteria for Defining the Naive Human Pluripotent State 1.04
RNA-seq of CD33 KO and control HSPCs 0.99
Recurrent alterations of TNFAIP3 (A20) in T-cell large granular lymphocytic leukemia 0.97
Inhibition of the integrin alpha-V beta-3 reverts the paradoxical effect of levothyroxine replacement during bexarotene therapy in cutaneous T-cell lymphoma 0.96
MicroRNA-125a-5p overexpression in human macrophages 0.96
Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 0.93
Human CD11b+ macrophages - Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 0.93
Genome-wide RNA deep sequencing of CAL-101 or AKTi primed human T cells in comparison to traditionally expanded T cells 0.88
The pioneer factor CEBPA modulates vitamin D signaling 0.88
Effects of transcription factor CEBPA knockdown on vitamin D target gene regulation in THP-1 cells 0.88
Transcriptome Analysis of PBMCs in peripheral blood of patients with hepatocellular carcinoma 0.86
Global response to chemotherapy-induced apoptosis 0.86
SOX11 knockdown in B-ALL cell lines 0.86
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing [RNA-Seq] 0.83
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing 0.83
RNA-seq analysis in knockdown Jurkat samples for each factor of TAL1 complex 0.82
Oncogenic roles of ARID5B in T-ALL 0.82
KSRP specifies monocytic and granulocytic differentiation through regulating miR-129 biogenesis and RUNX1 expression 0.79
Engineered Nanointerfaces for Microfluidic Isolation and Molecular Profiling of Tumor-specific Extracellular Vesicles 0.79
The expression profiles of GBC liver metastasis 0.79
FOXO1 is an oncogenic mediator in AML1-ETO leukemia 0.79
RNASeq of 4SU labelled nascent RNA in MV4;11 cell treated with DMSO, I-BET, SGC0946 and combination of I-BET and SGC0946 0.78
Viral infection enhances NK cell activation via Type I dependent pathways and can be utilized to enhance influenza-specific monoclonal antibody therapies 0.78
Intrinsic Plasma Cell Differentiation Defects in BENTA Patient B cells 0.77
Human macrophages exhibit high activity to clear intracellular biovar Microtus strain of Y. pestis 0.77
Characterization of Human Pegivirus Infection in Liver Transplantation Recipients 0.76
RNA sequencing of isogenic BRCA2 haploinsufficient vs. wild-type T-ALL cells 0.75
Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell Analyses 0.75
Expression Analysis of dic(1;7)(q10;p10) in Myelodysplastic Syndromes (MDS) compared to control cohort and therapy-related Myeloid Neoplasms (t-MN) 0.74
A Distinct Epigenetic Program Underlies the 1;7 Translocation in Myelodysplastic Syndromes (MDS) 0.74
Human Treg IL-12 stimulation 0.73
Inhibiting the oncogenic translation program is an effective therapeutic strategy in multiple myeloma 0.71
Profiling of lung tumor-infiltrating CD8 T cells according to their expression status of CD39 0.71
Expression of the mannose receptor (CD206) defines distinct populations of human colonic macrophages in health and inflammatory bowel disease 0.7
Single-cell transcriptomic analysis of tissue resident memory T cells in human lung cancer [ 10x genomics] 0.69
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of HSCe) 0.69
Transcriptomic analysis of primary human T cells and murine RAW 264.7 macrophages 3D cultured in different collagen densities 0.67
Next Generation Sequencing Facilitates Quantitative Analysis of Health donors and SLE patients' PBMC Transcriptomes 0.66
Comparative Transcriptomic Analysis of Hematopoietic System Across Species by Microwell-Seq 0.64
A specific missense mutation in GTF2I occurs at high frequency in thymic epithelial tumors 0.64
RNA-seq on Enasidenib or DMSO Treated CD71+ Cells from Umbilical Cord Blood (UCB) 0.64
Gene expression profile of differentially recognized Mtb-epitopes as a function of disease history 0.63
Global transcript structure resolution of high gene density genomes through multi-platform data integration: Illumina RNA-Seq 0.62
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with colorectal carcinoma 0.61
Leucegene: AML sequencing (part 6) 0.59
Transcriptome analysis of human reninomas as an approach to understanding juxtaglomerular cell biology 0.59
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 0.58
mRNA expression profile of Lymphocytes 0.58
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. 0.58
RNA sequencing of bone marrow CD34+ cells from myelodysplastic syndrome patients with and without SF3B1 mutation and from healthy controls 0.58
Canonical and non-canonical regulatory roles of androgen receptor variant 7 in prostate cancer 0.58
HSB-2 cells stably expressing LDB1 or mutant LDB1 proteins 0.56
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration 0.56
RNASeq of Healthy Human Skin Tregs and CD4 Teffs versus Psoriatic Human Skin Tregs and CD4 Teffs 0.55
Direct in vivo evidence for B-cell receptor and NF-KB activation in mantle cell lymphoma: role of the lymph node microenvironment and activating mutations. 0.55
Direct in vivo evidence for B-cell receptor and NF-KB activation in mantle cell lymphoma: role of the lymph node microenvironment and activating mutations. [RNA-Seq] 0.55
Mutated H3 Histones Drive Human Pre-Leukemic Hematopoietic Stem Cell Expansion And Promote Leukemic Aggressiveness 0.55
Integration of kinase and calcium signaling at the level of chromatin underlines inducible gene activation in T cells 0.54
CD48-dependent protective autophagy in conventional human T cells promotes restimulation-induced cell death resistance 0.53
Genome-wide maps of chromatin state and mRNA expression patterns in leukemic cell lines 0.53
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function 0.51
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function [RNAseq] 0.51
Transcriptome-wide analysis of IL2RA enhancer activation by CRISPRa 0.51
Transcriptome analysis of diverse cell types infected with human cytomegalovirus 0.51
Quantitative Proteomics Reveals a Unique Wiring of Signaling Pathways that Protects Human Regulatory T Cell Identity 0.49
Cooperation between TLX1 and the NUP214-ABL1/STAT5 signaling in T-cell acute lymphoblastic leukemia 0.48
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (TLR perturbation Bulk RNA-Seq) 0.48
RNA sequencing of T-ALL (COG study) 0.46
Analyses of T-ALL (COG study) 0.46
Gene expression profiles of PD1-high, PD1-intermediate, and PD1-negative tumor-infiltrating CD8 T cells in hepatocellular carcinoma 0.44
Long noncoding RNA ROCR contributes to SOX9 expression and chondrogenic differentiation of human mesenchymal stem cells 0.43
RNA-seq of Human neck of femur (NOF) fracture hip and osteoarthritic (OA) cartilage 0.43
The dynamics of cellular response to therapeutic perturbation using multiplexed quantification of the proteome and transcriptome at single-cell resolution 0.42
RNA sequencing data of whole blood cells of normal glucose tolerant (NGT) and gestational diabetes (GDM) pregnant women 0.41
Single-cell RNA-seq reveals differentiation of bona fide human pDCs and cDC1s in cultures of cord blood CD34+ progenitors, and a newly identified terminal differentiation step of cDC1s 0.4
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma (RNA-Seq) 0.39
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma 0.39
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation 0.39
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation [bulk RNA-Seq] 0.39
THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors 0.39
RNA-sequencing study of peripheral blood monocytes for chronic periodontitis 0.38
Gene expression activation in CLL mediated by MSCs contact 0.35
Self-associated molecular patterns mediate cancer immune evasion by engagement of Siglec receptors 0.35
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML [RNA-Seq human] 0.35
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML 0.35
RNA-seq study reveals unique transcriptome expression in systemic lupus erythematosus patients with distinct autoantibody profile 0.34
Frailty in middle age is associated with race-specific changes to the transcriptome. 0.33
Transcriptome profiling (RNA-seq) of CREBBP+/+ and CREBBP+/- clones of U2932 DLBCL cell line 0.3
Immunoglobulin transcript sequence and somatic hypermutation computation from unselected RNA-seq reads in Chronic Lymphocytic Leukemia 0.3
A single cell reference map for human blood and tissue T cell activation 0.29
Select correlative genes involved in pathogenesis of idiopathic interstitial pneumonia by high-throughput sequencing analysis 0.28
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia [scRNA-seq] 0.27
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia 0.27
Single-cell analysis reveals stochastic regulation of type I IFN production by plasmacytoid dendritic cells and identifies host-derived environmental cues as amplifier of type I IFN production 0.26
Organelle-based therapy for immune mediated disease: mitochondrial transfer elicits Tregs reprogramming 0.26
Lineage tracing of acute myeloid leukemia reveals the impact of hypomethylating agents on chemoresistance selection 0.25
The cytokine environment influence on human skin-derived T cells 0.23
Longitudinal transcriptome profiling of post-treatment Lyme disease syndrome 0.23
RNA seq analysis of human macrophages after treatment of glimepiride versus empagliflozin. 0.21
The role of m6A/m-RNA methylation in stress response regulation 0.18
m6A/m-Seq of human B-lymphocyte cell lines from healthy controls and major depressive disorder patients 0.18
Gene expression for surgically treated pancreatic cancer after one neoadjuvant vaccine dose 0.17
AML subtype is a major determinant of the association between prognostic gene expression signatures and their clinical significance. 0.15
MicroRNA-28 replacement for non-Hodgkin lymphoma therapy 0.15
Unique features and clinical importance of acute alloreactive immune responses 0.12
Widespread regulated alternative splicing of single codons accelerates proteome evolution 0.12
IL-10 dysregulation in acute mountain sickness revealed by transcriptome analysis 0.1
A Phase II Study of Pomalidomide, Daily Low Dose Oral Cyclophosphamide, and Dexamethasone in Relapsed/Refractory Multiple Myeloma 0.09
Expression of long non-coding RNAs in autoimmunity and linkage to enhancer function and autoimmune disease risk genetic variants 0.09
RNAseq analysis of ruxolitinib treated breast cancers 0.08
Human Tfh cell RNA bulk sequencing 0.06
Expression levels of genes of NKG2C+ NK cells after in vitro treatment 0.04
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 rescue] 0.02


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation